首页>
外国专利>
Use of the HAb18G / CD147 molecule as a target for antiviral antagonists and the antiviral antagonists thus obtained
Use of the HAb18G / CD147 molecule as a target for antiviral antagonists and the antiviral antagonists thus obtained
展开▼
机译:HAb18G / CD147分子用作抗病毒拮抗剂的靶标以及由此获得的抗病毒拮抗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to use of HAb 18G/CD 147 molecule as target for designing antiviral antagonist and the antiviral antagonist designed by using such molecule, especially antagonist against SARS Coronavirus and AIDS virus HIV-1. Antagonist of the present invention includes antibody, polypeptide, immune complex, derivative, small molecule compound and so on, which is able to prevent SARS Coronavirus and AIDS virus (HIV-1) from invading host cell, thereby exerts its antagonistic antiviral effect. It is provided by in vitro experiment that such antagonist has inhibitory effect against SARS Coronavirus and AIDS virus (HIV-1), thus is potential antiviral candidate drug.
展开▼
机译:本发明涉及HAb 18G / CD 147分子作为设计抗病毒拮抗剂的靶标的用途,以及使用该分子设计的抗病毒拮抗剂,特别是针对SARS冠状病毒和AIDS病毒HIV-1的拮抗剂。本发明的拮抗剂包括抗体,多肽,免疫复合物,衍生物,小分子化合物等,它们能够防止SARS冠状病毒和AIDS病毒(HIV-1)侵入宿主细胞,从而发挥其拮抗抗病毒作用。通过体外实验表明,该拮抗剂对SARS冠状病毒和AIDS病毒(HIV-1)具有抑制作用,因此是潜在的抗病毒候选药物。
展开▼